Microwave Ablation Shows High Efficacy for Liver Tumors

Surgical microwave ablation (MWA) proves to be a robust treatment for diverse liver tumors, with a low readmission rate of 6.5%. Analyzing 3,035 tumors across 1,416 patients over 16 years, median overall survival reached 3.9 years, varying by tumor type, while median recurrence-free survival stood at 2.2 years. Notably, MWA’s outcomes match or exceed those of traditional therapies, underscoring its potential for widespread clinical adoption in managing hepatic malignancies.